Cargando…

Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer

The androgen receptor (AR) is a pivotal target for the treatment of prostate cancer (PC) even when the disease progresses toward androgen-independent or castration-resistant forms. In this study, a series of 15 bicalutamide analogues (sulfide, deshydroxy, sulfone, and O-acetylated) were prepared and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kandil, Sahar B., McGuigan, Christopher, Westwell, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795644/ https://www.ncbi.nlm.nih.gov/pubmed/33374450 http://dx.doi.org/10.3390/molecules26010056

Ejemplares similares

ProTides of BVdU as potential anticancer agents upon efficient intracellular delivery of their activated metabolites
por: Kandil, Sahar, et al.
Publicado: (2016)

Novel cis-selective and non-epimerisable C3 hydroxy azapodophyllotoxins targeting microtubules in cancer cells
por: Kandil, Sahar, et al.
Publicado: (2016)

Structure-Based Virtual Screening, Synthesis and Biological Evaluation of Potential FAK-FAT Domain Inhibitors for Treatment of Metastatic Cancer
por: Kandil, Sahar B., et al.
Publicado: (2020)

Rational design and synthesis of novel phenylsulfonyl-benzamides as anti-prostate cancer agents
por: Bassetto, Marcella, et al.
Publicado: (2017)

Synthesis and biological evaluation of phosphoramidate prodrugs of two analogues of 2-deoxy-d-ribose-1-phosphate directed to the discovery of two carbasugars as new potential anti-HIV leads
por: Hamon, Nadège, et al.
Publicado: (2015)

Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides
por: McGuigan, Christopher, et al.
Publicado: (2013)

Synthesis and biological evaluation of prodrugs of 2-fluoro-2-deoxyribose-1-phosphate and 2,2-difluoro-2-deoxyribose-1-phosphate
por: Hamon, Nadege, et al.
Publicado: (2013)

Spectrophotometric Estimation of Bicalutamide in Tablets
por: Sancheti, P. P., et al.
Publicado: (2008)

Mesotherapy with Bicalutamide: A New Treatment for Androgenetic Alopecia
por: Gomez-Zubiaur, Alba, et al.
Publicado: (2023)

Design, synthesis and biological evaluation of 2′-deoxy-2′,2′-difluoro-5-halouridine phosphoramidate ProTides
por: Quintiliani, Maurizio, et al.
Publicado: (2011)

Bicalutamide Activated Oncolytic Adenovirus for the Adjuvant Therapy of High Risk Prostate Cancer
por: Johnson, Tamara Jane, et al.
Publicado: (2013)

Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer
por: Li, Yuezheng, et al.
Publicado: (2023)

Compression-Induced Phase Transitions of Bicalutamide
por: Szafraniec-Szczęsny, Joanna, et al.
Publicado: (2020)

Synthesis and Characterization of NUC-7738, an Aryloxy Phosphoramidate of 3′-Deoxyadenosine, as a Potential Anticancer Agent
por: Serpi, Michaela, et al.
Publicado: (2022)

Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer models
por: SQUILLACE, RACHEL M., et al.
Publicado: (2012)

The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer
por: Tian, Lei, et al.
Publicado: (2022)

Biological basis of behavior : a program
por: McGuigan, F. J. (Frank Joseph), 1924-1998
Publicado: (1963)

Radiosynthesis of [(18)F]-Labelled Pro-Nucleotides (ProTides)
por: Cavaliere, Alessandra, et al.
Publicado: (2020)

Synthesis and Biological Evaluation of New CRH Analogues
por: Papazacharias, Spyridon, et al.
Publicado: (2010)

Synthesis and Biological Evaluation of Carbocyclic Analogues of Pachastrissamine
por: Kwon, Yongseok, et al.
Publicado: (2015)

Synthesis and Biological Evaluation of New (−)‐Englerin Analogues
por: López‐Suárez, Laura, et al.
Publicado: (2016)

Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate Cancer()
por: Hongo, Hiroshi, et al.
Publicado: (2014)

A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure
por: Muramatsu, Tomoaki, et al.
Publicado: (2019)

Successful recovery from multiple organ failure associated with bicalutamide and leuprorelin acetate for prostate cancer
por: Saito, Seiichi
Publicado: (2019)

Effect of Bicalutamide Combined with Docetaxel on Serum PSA and VEGF Levels in Patients with Advanced Prostate Carcinoma
por: Guo, Zhaoxin, et al.
Publicado: (2022)

Anti‐flavivirus Activity of Different Tritylated Pyrimidine and Purine Nucleoside Analogues
por: McGuigan, Christopher, et al.
Publicado: (2016)

Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database
por: Beebe-Dimmer, Jennifer L., et al.
Publicado: (2018)

Bicalutamide-induced hepatotoxicity: A rare adverse effect
por: Hussain, Salwa, et al.
Publicado: (2014)

The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate—a long-term follow-up comparison and quality of life analysis
por: Dijkstra, Siebren, et al.
Publicado: (2016)

Bicalutamide-induced hypoxia potentiates RUNX2-mediated Bcl-2 expression resulting in apoptosis resistance
por: Browne, G, et al.
Publicado: (2012)

Prophylactic Breast Bud Radiotherapy for Patients Taking Bicalutamide: Should This Still Be Practised for Patients with Prostate Cancer?
por: Lewis, R., et al.
Publicado: (2012)

Findings of Gynecomastia That Developed in Follow-up Secondary to Bicalutamide Treatment on Bone Scan
por: Ünal, Kemal, et al.
Publicado: (2020)

Synthesis and Biological Evaluation of 7-Deoxy-Epothilone Analogues
por: Woods, Laura M., et al.
Publicado: (2017)

Synthesis, biological evaluation and toxicity of novel tetrandrine analogues
por: Schütz, Ramona, et al.
Publicado: (2020)

Correction to: Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database
por: Beebe-Dimmer, Jennifer L., et al.
Publicado: (2018)

The changing face of oesophageal cancer treatment in Northern Ireland.
por: McManus, K., et al.
Publicado: (1994)

Synthesis and biological evaluation of novel ursolic acid analogues as potential α-glucosidase inhibitors
por: Wu, Pan-Pan, et al.
Publicado: (2017)

Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial
por: Penson, David F., et al.
Publicado: (2021)

Data-Driven Modeling of the Bicalutamide Dissolution from Powder Systems
por: Mendyk, Aleksander, et al.
Publicado: (2020)

Physicochemical Profile of Antiandrogen Drug Bicalutamide: Solubility, Distribution, Permeability
por: Volkova, Tatyana V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_niq4gqfedn5adl9erp8n1vknnk